Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emodin is a naturally occurring anthraquinone derivative found in the roots and leaves of various plants such as Rheum palmatum (rhubarb) and Polygonum multiflorum. It has been used for centuries in traditional Chinese medicine. Emodin exhibits a wide range of biological activities including anti-inflammatory, antioxidant, anticancer, antimicrobial (antibacterial and antiviral), diuretic, antiulcerative and antinociceptive effects[1][3][4]. Mechanistically, emodin acts as an inhibitor of several cell signaling pathways involved in inflammation and cancer progression. It inhibits nuclear factor kappa-B (NF-κB), JNK/p38 MAPK/Erk1/2 pathways; suppresses pro-inflammatory cytokines such as TNF-α and IL-6; inhibits matrix metalloproteinases like MMP-9; modulates histone deacetylase activity; increases nitric oxide production via eNOS activation; and can inhibit 5-lipoxygenase (5-LOX)[4][5][6]. Emodin also promotes apoptosis in cancer cells by increasing reactive oxygen species (ROS) levels[8]. Despite promising preclinical data for conditions such as cancer, cardiovascular disease (including myocardial hypertrophy/fibrosis), metabolic disorders, liver diseases like hepatitis/cholelithiasis, ulcerative colitis and microbial infections[2][3][4], there are no approved clinical uses or robust human trial data to support its efficacy or safety for any indication[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on emodin.